This clinical-stage biotech focused on CNS disorders reported a notable insider sale amid ongoing development of its ...
In 2021, neurological diseases affected 3.40 billion individuals worldwide, corresponding to 43.1 % of the global population.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results